Lady Torres (@ladytorres2017) 's Twitter Profile
Lady Torres

@ladytorres2017

ID: 1202713810919968768

calendar_today05-12-2019 22:18:35

48 Tweet

33 Followers

56 Following

Lady Torres (@ladytorres2017) 's Twitter Profile Photo

This is an exciting time for Molecular Imaging as we move forward with precision medicine. It is so rewarding to get access for more accurate imaging for patients that will benefit greatly Jean Aime DagyV @Curtin_NYP NewYork-Presbyterian SNMMI

Weill Cornell Medicine (@weillcornell) 's Twitter Profile Photo

Dr. Joseph Osborne was a hospital intern in D.C. during 9/11. With his resilience and guidance from his mentors, he persevered. For #BlackHistoryMonth, we're highlighting #WCM faculty making history today. #WeillCornellBHM Learn about Dr. Osborne: bit.ly/3px6AxN

Dr. Joseph Osborne was a hospital intern in D.C. during 9/11. With his resilience and guidance from his mentors, he persevered.

For #BlackHistoryMonth, we're highlighting #WCM faculty making history today. #WeillCornellBHM

Learn about Dr. Osborne: bit.ly/3px6AxN
Kritika Subramanian (@krkksub) 's Twitter Profile Photo

Late post - now online! Can’t wait for us to showcase the power of this tool in the subsequent manuscript. Artificial Intelligence based segmental quantification of pulmonary perfusion for pre-transplant workup. jnm.snmjournals.org/content/62/sup… #SNMMI2021 Siemens Healthineers WCM Molecular Imaging and Therapeutics

Weill Cornell Medicine (@weillcornell) 's Twitter Profile Photo

#WCM is a frontrunner in the early detection and treatment of prostate cancer. Dr. Joseph Osborne (@Osborne10Joseph) of WCM Molecular Imaging and Therapeutics and NewYork-Presbyterian discusses advances in PSMA PET-imaging for detecting prostate cancer and improving outcomes. bit.ly/2X8ZXsO

#WCM is a frontrunner in the early detection and treatment of prostate cancer.

Dr. Joseph Osborne (@Osborne10Joseph) of <a href="/MolecularWCM/">WCM Molecular Imaging and Therapeutics</a> and <a href="/nyphospital/">NewYork-Presbyterian</a> discusses advances in PSMA PET-imaging for detecting prostate cancer and improving outcomes. bit.ly/2X8ZXsO
Lady Torres (@ladytorres2017) 's Twitter Profile Photo

Today our new scanner has arrived WCM Molecular Imaging and Therapeutics we are excited to advance our department as we continue to provide patients with access to the most innovative technology in Molecular Imaging!!! Thank you all who made this possible Jean Aime @Curtin_NYP

Today our new scanner has arrived <a href="/MolecularWCM/">WCM Molecular Imaging and Therapeutics</a> we are excited to advance our department as we continue to provide patients with access to the most innovative technology in Molecular Imaging!!! Thank you all who made this possible <a href="/Jean_NYP/">Jean Aime</a> @Curtin_NYP
Weill Cornell Medicine (@weillcornell) 's Twitter Profile Photo

Dr. Joseph Osborne (@JOsbMD), Dr. Neil Bander (Neil H Bander MD) and Scott Tagawa provide commentary on prostate-specific membrane antigen PET and the new algorithm for prostate cancer patients. bit.ly/39kAIa7

Dr. Joseph Osborne (@JOsbMD), Dr. Neil Bander (<a href="/BanderNeil/">Neil H Bander MD</a>) and <a href="/DrScottTagawa/">Scott Tagawa</a> provide commentary on prostate-specific membrane antigen PET and the new algorithm for prostate cancer patients.

bit.ly/39kAIa7
Juana Martinez (@juamartinezz) 's Twitter Profile Photo

68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective…⁦@JOsbMD⁩ ⁦Kritika Subramanian⁩ ⁦Himanshu Nagar⁩ ⁦Sandra Huicochea Castellanos⁩ ⁦WCM Molecular Imaging and Therapeutics⁩ sciencedirect.com/science/articl…

Weill Cornell Medicine Meyer Cancer Center (@wcm_meyercancer) 's Twitter Profile Photo

#ICYMI April 19 marked a major step forward for precision oncology. WCM Molecular Imaging and Therapeutics administered their first Pluvicto Treatment today. Pluvicto is the first FDA approved radiolig and therapy for patients with prostate cancer. Weill Cornell Medicine @JOsbMD Scott Tagawa

#ICYMI April 19 marked a major step forward for precision oncology. 
<a href="/MolecularWCM/">WCM Molecular Imaging and Therapeutics</a> administered their first Pluvicto Treatment today. Pluvicto is the first FDA approved radiolig and therapy for patients with prostate cancer. 
<a href="/WeillCornell/">Weill Cornell Medicine</a> @JOsbMD <a href="/DrScottTagawa/">Scott Tagawa</a>